XML 33 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Class A Non-voting Common Stock
Class A Non-voting Common Stock
Common Stock
Common Class B Stock Conversion from Class C Voting Common Stock
Common Stock
Class C Voting Common Stock
Class C Voting Common Stock
Common Stock
Class B Voting Common Stock
Class B Voting Common Stock
Common Stock
Balance, beginning of period, shares at Dec. 31, 2017             883,022     216,616   122,564
Balance, beginning of period at Dec. 31, 2017   $ 7,634,825 $ (4,656,667)   $ 14,157   $ 9     $ 2   $ 1
Shares issued in connection with exercise of stock options under stock-based compensation plans, shares             15,856         3,414
Shares issued in connection with exercise of stock options under stock-based compensation plans   47,988                    
Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, shares             64,831         3,502
Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, net             $ 1          
Conversion of stock to voting/non-voting common stock, shares             35,634         (35,634)
Issuance of Class C voting common stock for settlement of restricted stock awards net, Shares                   7,995    
Stock-based compensation expense   538,211                    
Stock repurchases from employees for tax withholdings   (607)                    
Stock repurchases from employees for tax withholdings, shares             (39)          
Net loss $ (1,255,911)   (1,255,911)     $ (921,235)     $ (239,779)   $ (94,897)  
Other comprehensive income (loss), net of tax $ (11,010)       (11,010)              
Balance, end of period, shares at Dec. 31, 2018 1,317,761           999,304     224,611   93,846
Balance, end of period at Dec. 31, 2018 $ 2,310,999 8,220,417 (5,912,578) $ 308 3,147   $ 10     $ 2   $ 1
Shares issued in connection with exercise of stock options under stock-based compensation plans, shares             3,291         1,389
Shares issued in connection with exercise of stock options under stock-based compensation plans   16,567                    
Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, shares             86,519         300
Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, net             $ 1          
Issuance of Class A non-voting common stock in connection with acquisitions and divestitures   6,913                    
Conversion of stock to voting/non-voting common stock, shares             71,013         (71,013)
Conversion of stock to voting/non-voting common stock             $ 1         $ (1)
Issuance of Class C voting common stock for settlement of restricted stock awards net, Shares                   6,536    
Stock-based compensation expense   686,013                    
Equity component of convertible senior notes, net   377,432                    
Purchase of Capped Calls   (102,086)                    
Net loss (1,033,660)   (1,033,660)     (817,156)     (183,164)   (33,341)  
Other comprehensive income (loss), net of tax $ (2,574)       (2,574)              
Balance, end of period, shares at Dec. 31, 2019 1,415,796           1,160,127     231,147   24,522
Balance, end of period at Dec. 31, 2019 $ 2,259,913 9,205,256 (6,945,930) $ (773) 573   $ 12     $ 2    
Shares issued in connection with exercise of stock options under stock-based compensation plans, shares             3,824         754
Shares issued in connection with exercise of stock options under stock-based compensation plans   34,209                    
Issuance of voting/non-voting common stock for vesting of restricted stock units and restricted stock awards, shares             78,042          
Issuance of Class A non-voting common stock in connection with acquisitions and divestitures   3,003                    
Conversion of stock to voting/non-voting common stock, shares             6,017 4,437   (4,437)   (6,017)
Issuance of Class C voting common stock for settlement of restricted stock awards net, Shares                   4,917    
Stock-based compensation expense   771,084                    
Equity component of convertible senior notes, net   286,589                    
Purchase of Capped Calls   (100,000)                    
Net loss (944,839)   (944,839)     $ (775,801)     $ (153,461)   $ (15,577)  
Other comprehensive income (loss), net of tax $ 20,790       20,790              
Balance, end of period, shares at Dec. 31, 2020 1,503,333           1,248,010     231,627   23,696
Balance, end of period at Dec. 31, 2020 $ 2,329,976 $ 10,200,141 $ (7,891,542)   $ 21,363   $ 12     $ 2